ArticleNature communications2025
A polycyclic scaffold identified by structure-based drug design effectively inhibits the human P2X7 receptor.
Adam C Oken et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it